MEMORY EXPRESS ZERTIFIKAT - PFIZER INC/ELI LILLY & CO | Delayed Deutsche Boerse AG 05:50:51 20/05/2024 pm IST | ||
| 77.29 EUR | +0.57% |
|
| Current month | +16.58% | ||
| 1 month | +18.61% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 20/24/20 | 77.29 | +0.57% |
| 17/24/17 | 76.85 | -0.68% |
| 16/24/16 | 77.38 | -0.68% |
| 15/24/15 | 77.91 | +1.62% |
| 14/24/14 | 76.67 | -0.84% |
Delayed Quote Deutsche Boerse AG
Last update May 20, 2024 at 05:50 pm IST
More quotesStatic data
| Product type | sonstige Zertifikate |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
BNP Paribas
|
| WKN | PF99LH |
| ISIN | DE000PF99LH6 |
| Date issued | 04/03/2022 |
| Strike | 250 $ |
| Maturity | 01/03/2027 (1015 Days) |
| Parity | 0.25 : 1 |
| Emission price | 100 € |
| Emission volume | N/A |
| Settlement | Beides |
| Currency | EUR |
Technical Indicators
| Highest since issue | 107.6 € |
|---|---|
| Lowest since issue | 63.04 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
770
USD
Average target price
850.4
USD
Spread / Average Target
+10.44%
- Stock Market
- Certificates
- Certificat
